Tissue transglutaminase (transglutaminase 2) is a multifunctional enzyme with many interesting properties resulting in versatile roles in both physiology and pathophysiology. Herein, the particular involvement of the enzyme in human diseases will be outlined with special emphasis on its role in cancer and in tissue interactions with biomaterials. Despite recent progress in unraveling the different cellular functions of transglutaminase 2, several questions remain. Transglutaminase 2 features in both confirmed and some still ambiguous roles within pathological conditions, raising interest in developing inhibitors and imaging probes which target this enzyme. One important prerequisite for identifying and characterizing such molecular tools are reliable assay methods to measure the enzymatic activity. This digest Letter will provide clarification about the various assay methods described to date, accompanied by a discussion of recent progress in the development of inhibitors and imaging probes targeting transglutaminase 2. © 2013 Elsevier Ltd. All rights reserved.
Pietsch, M., Wodtke, R., Pietzsch, J., & Löser, R. (2013, December 15). Tissue transglutaminase: An emerging target for therapy and imaging Dedicated to Professor Jörg Steinbach, Dresden-Rossendorf, on the occasion of his 60th birthday. Bioorganic and Medicinal Chemistry Letters. Elsevier Ltd. https://doi.org/10.1016/j.bmcl.2013.09.060